Litcius/Paper detail

The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer.

Rong Cong, Fanfei Kong, Jian Ma, Qing Li, Hui Yang, Xiaoxin Ma

2021PubMed21 citationsOpen Access PDF

Abstract

assays. Molecule interactions were illustrated by co-transfection assays. The bioinformatics analysis showed that PVT1/miR-612/CENP-H/CDK1 axis played a vital role in the malignant progression of advanced EC. MiR-612 was downregulated in EC tissues and acted as a tumour suppressor to inhibit cell proliferation, migration, invasion, and promote cell apoptosis. CENP-H was found overexpressed in EC tissues, and the expression level was correlated to diagnosis and prognosis of EC. Hyperactivated CENP-H promoted cell proliferation, migration, invasion, and inhibited cell apoptosis. Overexpressed CENP-H prevented the anti-tumour effects observed with upregulated miR-612; knockdown of miR-612 also suppressed the anti-tumour effects of downregulated PVT1. Knockdown of PVT1 together with upregulated miR-612 exerted the strongest anti-tumour effects in nude mice. These effects were mediated by CDK1 through modulation of the Akt/mTOR signaling pathway. In conclusion, the PVT1/miR-612/CENP-H/CDK1 axis promoted the malignant progression of advanced EC and could serve as a promising target for potential treatments.

Topics & Concepts

PVT1Competing endogenous RNAGene knockdownCancer researchBiologyCell growthCyclin-dependent kinase 1ApoptosisDownregulation and upregulationLong non-coding RNACell cycleGeneGeneticsCancer-related molecular mechanisms researchRNA Research and SplicingCircular RNAs in diseases
The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer. | Litcius